MarcEdwardAgroninMD

Geriatric Psychiatry

Chief Medical Officer, Frank C. and Lynn Scaduto MIND Institute and Behavioral Health at Miami Jewish Health Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Join to view full profile

Dr. Agronin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Agronin's full profile

Already have an account?

Office
5200 NE 2nd Ave
Miami, FL 33137
Phone+1 305-751-8626

Fax+1 305-762-1439

Summary

Dr. Marc Agronin is a psychiatrist in Miami, FL. He received his medical degree from Yale University School of Medicine and has been in practice 26 years. He also speaks multiple languages, including Spanish. He specializes in geriatric psychiatry and is experienced in dementia, lewy body dementia, vascular dementia, aging, and alzheimer disease.

Marc Agronin MD - Aging Author Official Website - Geriatric Psychiatrist

Marc E. Agronin, MD, a summa cum laude graduate of Harvard University and the Yale School of Medicine, is a board-certified adult and geriatric psychiatrist and

Education & Training

University of MinnesotaFellowship, Geriatric Psychiatry, 1995 - 1996
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1991 - 1995
Yale School of MedicineClass of 1991
Harvard UniversityBA, Psychology and Philosophy, Summa cum laude, 1983 - 1987

Certifications & Licensure

FL State Medical License 1999 - 2026
MA State Medical License 1992 - 1999
MN State Medical License 1998 - 1999
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Geriatric Psychiatry

Awards, Honors, & Recognition

President elect American Association for Geriatric Psychiatry, 2022
Distinguished Fellow American Psychiatric Association
Distinguished Fellow American Association for Geriatric Psychiatry, 2018
Excellence in Research and Education Award LeadingAge, 2013
Clinician of the Year American Association for Geriatric Psychiatry, 2008
Join now to see all

Clinical Trials

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease Start of enrollment: 2012 Oct 01
Completed
Phase 3
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Effect of NeuroAD on the Cognitive Function of Alzheimer Patients Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
18F-AV-1451 Autopsy Study Start of enrollment: 2015 Sep 01
Completed
Phase 3
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease Start of enrollment: 2015 Jul 01
Completed
Phase 1, Phase 2
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Terminated
Phase 3
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) Start of enrollment: 2016 Oct 29
Active, not recruiting
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease Start of enrollment: 2018 Dec 13
Completed
Phase 2, Phase 3
Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care Start of enrollment: 2024 Jul 01
Not yet recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

117 citations
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial
Jeffrey L. Cummings, Constantine G. Lyketsos, Elaine R. Peskind, Anton P. Porsteinsson, Jacobo Mintzer
JAMA. 2015-09-22
12 citations
Cannabinoids for Agitation in Alzheimer's Disease.
John D. Outen, M. Haroon Burhanullah, Ryan Vandrey, Halima Amjad, David G. Harper
The American Journal of Geriatric Psychiatry. 2021-01-27
8 citations
Study rationale and baseline data for pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's dementia (THC-AD).
Leah Cohen, Eleanor Ash, John D. Outen, Ryan Vandrey, Halima Amjad
International Psychogeriatrics. 2021-10-11

Books/Book Chapters

The End of Old Age: Living a Longer, More Purposeful Life
Marc E. Agronin, M.D.Da Capo Press, Boston2018
How We Age: A Doctor's Journey into the Heart of Growing Old
Marc Agronin, MDEditors: Da Capo / Perseus.2011

Lectures

26th Annual U.S. Psychiatric and Mental Health Congress 2013
CME LLC (A NACCME subsidiary), Las Vegas, Nevada - 9/30/2013
26th Annual U.S. Psychiatric and Mental Health Congress 2013
CME LLC (A NACCME subsidiary), Las Vegas, Nevada - 9/30/2013
15th Annual Primary Care Update Session II
Continuing Medical Education Institute, Inc, Marco Island, Florida - 4/2/2012
15th Annual Primary Care Update - Spring Conference
Continuing Medical Education Institute, Inc, Fort Lauderdale, Florida - 3/26/2012
Join now to see all

Authored Content

What Covid-19 Taught Us About the High Cost of IsolationApril 2021

Press Mentions

Speeding up Alzheimer's Diagnoses: Florida Doctors Discuss New Blood TestsAugust 17th, 2024
Dementia Diet: Breakfast Spread ‘May Increase Behavioural Symptoms’ – What to Eat InsteadAugust 2nd, 2022
Dr. Marc Agronin Honored as the 2022 Distinguished Ambassador in AgingApril 6th, 2022
Join now to see all

Professional Memberships

American Psychiatric Association - APA
Member and Distinguished Fellow
American Association for Geriatric Psychiatry
Member, Distinguished Fellow and President Elect